Answers are grounded in this paper and cite their sources.
On the basis of these preliminary results, treatment of patients who have acromegaly with a growth hormone-receptor antagonist results in a reduction in serum IGF-I concentrations and in clinical improvement.
No takes yet. Share an insight, caveat, or question.
Trainer et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: